Sensitivity, specificity, and positive predictive value of technetium 99-HMPAO SPECT in discriminating Alzheimer's disease from other dementias

Journal of Geriatric Psychiatry and Neurology

Volumn 10, Issue 1, 1997, Pages 15-21

  Masterman, Donna L ^a   Mendez, Mario F ^a   Fairbanks, Lynn A ^b   Cummings, Jeffrey L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Los Angeles ^*

Author keywords

[No Author keywords available]

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M;

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMENTIA; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY; PREDICTION; PRIORITY JOURNAL; SINGLE BLIND PROCEDURE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYMPTOM;

EID: 0030940155     PISSN: 08919887     EISSN: None     Source Type: Journal    
DOI: 10.1177/089198879701000104     Document Type: Article

References (50)

1. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984; 34:939-944.
2. Mölsa PK, Paljärvi L, Rinne JO, et al. Validity of clinical diagnosis in dementia: a prospective clinicopathological study. J Neurol Neurosurg Psychiatry 1985; 48:1085-1090.
3. Van Gool WA, Walstra GJM, Teunisse S, et al. Diagnosing Alzheimer's disease in elderly, mildly demented patients: the impact of routine single photon emission computed tomography. J Neurol 1995; 242:401-405.
4. Bonte FJ, Hom J, Tintner R, Weiner MF. Single photon tomography in Alzheimer's disease and the dementias. Semin Nucl Med 1990; 20:342-352.
5. Burns A, Philpot MP, Costa DC, et al. The investigation of Alzheimer's disease with single photon emission tomography. J Neurol Neurosurg Psychiatry 1989; 52:248-253.
6. 99mTc HM-PAO: a SPECT study. J Comput Assist Tomogr 1987; 11:398-402.
7. Jagust WJ. Functional imaging in dementia: an overview. J Clin Psychiatry 1994; 55(11 suppl):5-11.
8. Johnston KA, Holman BL, Mueller SP, et al. Single photon emission computed tomography in Alzheimer's disease. Arch Neurol 1988; 45:392-396.
9. Neary D, Snowden JS, Shields RA, et al. Single photon emission tomography using 99mTc-HMPAO in the investigation of dementia. J Neurol Neurosurg Psychiatry 1987; 50:1101-1109.
10. Duara R, Grady C, Haxby J, et al. Positron emission tomography in Alzheimer's disease. Neurology 1986; 36:879-887.
11. 18 F) fluorodeoxyglucose. J Comput Assist Tomogr 1983; 7:590-598.
12. Eberling JL, Jagust WJ, Reed BR, Baker MG. Reduced temporal lobe blood flow in Alzheimer's disease. Neurobiol Aging 1992; 13:483-491.
13. Johnson KA, Holman L, Rosen J, et al. Iofetamine I 123 single photon emission computed tomography is accurate in the diagnosis of Alzheimer's disease. Arch Intern Med 1990; 150:752-756.
14. Perani D, Di Piero V, Vallar G, et al. Technetium-99m HM-PAO SPECT study of regional cerebral perfusion in early Alzheimer's disease. J Nucl Med 1988; 29:1507-1514.
15. Reed BR, Jagust WJ, Seab JP, Ober BA. Memory and regional cerebral blood flow in mildly symptomatic Alzheimer's disease. Neurology 1989; 39:1537-1539.
16. Houston AS, Kemp PM, Macleod MA. A method for assessing the significance of abnormalities in HMPAO brain SPECT images. J Nucl Med 1994; 35:239-244.
17. Jagust WJ, Budinger TF, Reed BR. The diagnosis of dementia with single photon emission computed tomography. Arch Neurol 1987; 44:258-262.
18. 99mTc]-HM-PAO in the diagnosis of primary degenerative dementia. J Cereb Blood Flow Metab 1988; 8(suppl):S123-S126.
19. Bonte FJ, Tintner R, Weiner MF, et al. Brain blood flow in the dementias: SPECT with histopathologic correlation. Radiology 1993; 186:361-365.
20. Jobst KA, Smith AD, Barker CS, et al. Association of atrophy of the medial temporal lobe with reduced blood flow in the posterior parietotemporal cortex in patients with a clinical and pathological diagnosis of Alzheimer's disease. J Neurol Neurosurg Psychiatry 1992; 55:190-194.
21. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198.
22. Boller F, Lopez OC, Moossy J. Diagnosis of dementia: clinicopathologic correlation. Neurology 1989; 39:76-79.
23. Kukull WA, Larson EB, Reifler BV, et al. The validity of 3 clinical diagnostic criteria for Alzheimer's disease. Neurology 1990; 40:1364-1369.
24. Risse SC, Sumi SM, Lampe TH, et al. Clinical diagnosis and neuropathological findings in Alzheimer's disease. Am J Psychiatry 1990; 147:168-172.
25. Sulkava R, Haltia M, Paetau A, et al. Accuracy of clinical diagnosis in primary degenerative dementia: correlation with neuropathological findings. J Neurol Neurosurg Psychiatry 1983; 46:9-13.
26. Ebmeier KP, Besson JAO, Crawford JR, et al. Nuclear magnetic resonance imaging and single photon emission tomography with radio-iodine labeled compounds in the diagnosis of dementia. Acta Psychiatr Scand 1987; 75:549-556.
27. Gemmell HG, Sharp PF, Besson JAO, et al. A comparison of TC-99m HM-PAO and I-123 IMP cerebral SPECT images in Alzheimer's disease and multi-infarct dementia. Eur J Nucl Med 1988; 14:463-466.
28. Gemmell HG, Sharp PF, Smith FW, et al. Cerebral blood flow measured by SPECT as a diagnostic tool in the study of dementia. Psychiatry Res 1989; 29:327-329.
29. Hanyu H, Abe S, Arai H, et al. Diagnostic accuracy of single photon emission computed tomography in Alzheimer's Disease. Gerontology 1993; 39:260-266.
30. Holman BL, Johnson KA, Gerada B, et al. The scintigraphic appearance of Alzheimer's disease: a prospective study using Technetium-99m-HMPAO SPECT. J Nucl Med 1992; 33:181-185.
31. Claus JJ, van Harskamp F, Breteler MMB, et al. The diagnostic value of SPECT with Tc 99m HMPAO in Alzheimer's disease: a population-based study. Neurology 1994; 44:454-461.
32. 99mTcd,1,-HMPAO SPECT study. J Neurol Neurosurg Psychiatry 1994; 57:285-295.
33. O'Mahony D, Coffey J, Murphy J, et al. The discriminate value of semiquantitative SPECT data in mild Alzheimer's disease. J Nucl Med 1994; 35:1450-1455.
34. Miller BL, Mena I, Daly J, et al. Temporo-parietal hypoperfusion with SPECT in conditions other than Alzheimer disease. Dementia 1990; 1:41-45.
35. Sawada H, Udaka F, Kameyama M, et al. SPECT findings in Parkinson's disease associated with dementia. J Neurol Neurosurg Psychiatry 1993; 55:960-963.
36. Johnson KA, Mueller ST, Walshe TM, et al. Cerebral perfusion imaging in Alzheimer's disease: use of single photon emission computed tomography and iofetamine hydrochloride I-123. Arch Neurol 1987; 44:165-168.
37. Grunwald F, Zierz S, Broich K, et al. HMPAO-SPECT imaging resembling Alzheimer-type dementia in mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS). J Nucl Med 1990; 31:1740-1742.
38. Sultzer DL, Mahler ME, Cummings JL, et al. Cortical abnormalities associated with subcortical lesions in vascular dementia: clinical and PET findings. Arch Neurol 1995; 52:773-780.
39. Sharp P, Gemmell H, Cherryman G, et al. Application of iodine-123-labeled isopropylamphetamine imaging to the study of dementia. J Nucl Med 1986; 27:761-768.
40. Smith FW, Besson JAO, Gemmell HG, et al. The use of technetium-99-m-HM-PAO in the assessment of patients with dementia and other neuropsychiatric conditions. J Cereb Blood Flow Metab 1988; 8(suppl 1):S116-S122.
41. Prohovnik I, Mayeux R, Sackeim HA, et al. Cerebral perfusion as a diagnostic marker of early Alzheimer's disease. Neurology 1988; 38:931-937.
42. Hellman RS, Tikofsky RS, Collier BD, et al. Alzheimer disease: quantitative analysis of I-123-iodoamphetamine SPECT brain imaging. Radiology 1989; 172:183-188.
43. 99mTc HM-PAO in the routine evaluation of Alzheimer's disease. Can J Neurol Sci 1991; 18:59-62.
44. Johnson KA, Kijewski MF, Becker JA, et al. Quantitative brain SPECT in Alzheimer's disease and normal aging. J Nucl Med 1993; 34:2044-2048.
45. Cohen MB, Graham LS, Lake R, et al. Diagnosis of Alzheimer's disease and multiple infarct dementia by tomographic imaging of iodine-123-IMP. J Nucl Med 1986; 27:769-774.
46. Deutsch G,Tweedy JR. Cerebral blood flow in severity-matched Alzheimer and multi-infarct patients. Neurology 1987; 37:431-438.
47. 99mTc-hexamethyl-propyleneamine oxime single photon emission. Arch Neurol 1994; 51:1198-1204.
48. Risberg J. Regional cerebral blood flow abnormalities in dementia of Alzheimer type. In: Fowler CJ, Carlson LA, Gottfries CG, Winblad B, eds. Biological markers in dementia of Alzheimer type. London: Smith Gordon; Niigata-Shi, Japan: Nishimura, 1990:61-68.
49. Tierney MC, Fisher RH, Lewis AJ, et al. The NINCDS-ADRDA work group criteria for the clinical diagnosis of probable Alzheimer's disease: a clinicopathologic study of 57 cases. Neurology 1988; 38:359-364.
50. McMurdo MET, Grant DJ, Kennedy NSJ, et al. The value of HMPAO SPECT scanning in the diagnosis of early Alzheimer's disease in patients attending a memory clinic. Nucl Med Commun 1994; 15:405-409.